# Meghmani Organics share price today (Meghmani Organics Ltd, NSE: MOL)

> Meghmani Organics share price today: ₹55.25 at the NSE close on 3 November 2026, down 31.8% in a year. Meghmani Organics (NSE: MOL) is worth ₹1,404 crore, trades at a P/E of 21.8 and has closed between ₹39.40 and ₹74.57 over the past 52 weeks. > Meghmani Organics Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. MOL · Pesticides/Agrochemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/meghmani-organics-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹55.25 (−31.8% in a year)
- P/E: 21.8× (higher than 58% of the last 5.2 years)
- Revenue (Jun 2026): ₹543 Cr (−11.6% on a year ago)
- Profit (Jun 2026): ₹48.0 Cr (+269.2% on a year ago)
- Operating margin: 18.0% (+7.0 points on a year ago)
- ROCE: 7%, FY26
- ROIC: 2.4%, against a 12.0% cost of capital: −9.6 points
- Profit that came in as cash: 86%, last 3 years

Biggest thing to watch: the price has already been rising for 3 weeks, so timing is the risk more than the business. ## What is the Meghmani Organics share price today? Meghmani Organics Ltd's share price was ₹55.25 at the close on 3 November 2026. It has been rising for 3 weeks. That is 5.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹39 and ₹75, and at that close it sat 45% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running. Over the last 5.2 years the share price moved −41% while the NIFTY 500 moved +55%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Meghmani Organics this quarter? Two changes stood out: best operating margin in 15 quarters and highest quarterly profit in 13 quarters. 1. Best operating margin in 15 quarters Operating margin was 18% in the June 2026 quarter, against 11% a year earlier. From the earnings call on 28 Sep 2026. 2. Highest quarterly profit in 13 quarters Profit of ₹48 crore in the June 2026 quarter is the highest of the last 13 quarters. ## What are Meghmani Organics' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Meghmani Organics reported revenue of ₹543 crore, down 11.6% from ₹614 crore a year earlier, and a profit of ₹48.0 crore, up 269.2% from ₹13.0 crore. ### Meghmani Organics results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹543 crore | ₹614 crore | −11.6% |
| Profit | ₹48.0 crore | ₹13.0 crore | +269.2% |
| Earnings per share | ₹1.89 | ₹0.50 | +278.0% |
| Operating margin | 18.0% | 11.0% | +7.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Meghmani Organics' management discussed these results on a call held on 28 September 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Meghmani Organics share price history? Meghmani Organics closed at ₹55.25 on 3 November 2026, down 31.8% from ₹81.07 a year earlier (31 October 2025) and down 46.8% over five years. Its highest weekly close since August 2021 was ₹139.15 on 22 July 2022. ### Meghmani Organics share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹51.85 | +6.6% |
| 1 month ago · 1 Oct 2026 | ₹55.13 | +0.2% |
| 6 months ago · 30 Apr 2026 | ₹48.93 | +12.9% |
| 1 year ago · 31 Oct 2025 | ₹81.07 | −31.8% |
| 3 years ago · 3 Nov 2023 | ₹74.75 | −26.1% |
| 5 years ago · 4 Nov 2021 | ₹103.90 | −46.8% |
| Earliest weekly close in our records · 20 Aug 2021 | ₹93.70 | −41.0% |
| Highest weekly close since August 2021 · 22 Jul 2022 | ₹139.15 | −60.3% |
| Lowest weekly close since August 2021, also the 52-week low · 27 Mar 2026 | ₹39.40 | +40.2% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹74.57 | −25.9% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (277 weekly closes from 20 August 2021 to 3 November 2026.)

## What is the latest news on Meghmani Organics? 3 Nov 2026: Meghmani Organics closed at ₹55.25, up 6.6% on the week and up 0.2% on the month. 28 Sep 2026: Meghmani Organics held its results call for April to June 2026. Management guided: Consolidated and Crop Protection topline growth in double digits over the next 3-5 years; technical/formulation mix planned toward 50:50 from 60:40. ### Earlier

- Results for April to June 2026: Revenue down 11.6% and profit up 269.2% on a year earlier. ## What dividend does Meghmani Organics pay? Meghmani Organics paid no dividend in the 12 months to 4 November 2026. The last was a dividend of ₹1.40 a share, ex-date 20 June 2023. ### Meghmani Organics dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 20 Jun 2023 | ₹1.40 | Dividend | same day |
| 17 Jun 2022 | ₹1.40 | Dividend | 20 Jun 2022 |
| 15 Sep 2021 | ₹1.40 | Dividend | n/a |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 3 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Meghmani Organics Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 4 of its last 7 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Meghmani Organics management say on the latest results call? On the call for April to June 2026, held on 28 September 2026, Meghmani Organics' management guided: Consolidated and Crop Protection topline growth in double digits over the next 3-5 years; technical/formulation mix planned toward 50:50 from 60:40. > “We already have the capital blocks available for future growth, so for the next 1 or 2 years, we do not need any significant capex.”
> Ankit Patel, on the call for April to June 2026

### What management guided

- No significant capital spending over the next 1-2 years; maintenance spend ₹20-30 crore annually and regulatory registration spend averages ₹10 crore. - Pigment revenue ₹600-650 crore with operating margin 7-10%. - Crop Nutrition operating margin approximately 20% as the segment scales. - Consolidated term loans around ₹160 crore by 31 March 2027 and below ₹100 crore the following financial year. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/44981-28-Sep-2026.pdf). (From the call for April to June 2026, 28 September 2026.)

## What to watch in Meghmani Organics' next results? When Meghmani Organics reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Amalgamation to reach ROC effectiveness and unified reporting - check the next results packet for completion and cost-efficiency commentary. - What to check (from the call)
- Amalgamation to reach ROC effectiveness and unified reporting - check the next results packet for completion and cost-efficiency commentary. - Crop Protection utilisation and registration-led volume conversion - check next-quarter commentary for movement from the current operating range. - Pigment profitability after lower-cost inventory benefit - check next quarter for sustained efficiency and tariff-normalisation benefits. - Kilburn restart, conversion or continued suspension - check for any change in sulfuric-acid economics or anti-dumping duty status. ## Which stock lists is Meghmani Organics on? Meghmani Organics is on 3 of our India lists: Undervalued stocks, Breakout stocks and Penny stocks. - [Undervalued stocks Profit growth x: 3.2](https://www.sectoralpha.in/markets/in/deep-value-stocks)
- [Breakout stocks Breakout date: 30 October 2026](https://www.sectoralpha.in/breakout-stocks-india)
- [Penny stocks Earnings growth, 12 months (%): 236](https://www.sectoralpha.in/penny-stocks-india)

## Is Meghmani Organics profitable? Meghmani Organics Ltd earned ₹48.0 Cr of net profit in the Jun 2026 quarter, +269.2% on the same quarter a year earlier. Full-year FY26 profit was ₹29.0 Cr. Over 6 years profit has grown −24.0% a year on average. That is 8.8% of the quarter's revenue. The same quarter a year earlier earned ₹13.0 Cr. 7 of the last 12 reported quarters were loss-making. ## How much revenue does Meghmani Organics make, and is it growing? Meghmani Organics Ltd reported ₹543 Cr of revenue in the Jun 2026 quarter, −11.6% on the same quarter a year earlier. Over 6 years it has grown 20.8% a year on average. The last full year, FY26, came in at ₹2,174 Cr. The last four reported quarters add to ₹2,103 Cr. FY26 revenue was ₹2,174 Cr, +4.5% on the year before. Recent pace: the last four quarters grew −7.6% on average, against 20.8% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −7.8%, against +16.3% a year over the last 8 quarters (rolling over). ## How much of every ₹100 of sales does Meghmani Organics keep? Meghmani Organics Ltd's operating margin was 18.0% in the Jun 2026 quarter, 7.0 percentage points higher than the same quarter a year ago. Across 7 years it has been between −1.2% and 17.0%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +7.1 percentage points on the year while gross margin changed +8.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Meghmani Organics' profit turning into cash? Over the last 3 years, 86% of Meghmani Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹222 Cr of operating cash against ₹29.0 Cr of profit. After ₹42.0 Cr of spending on assets, ₹180 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 86% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Meghmani Organics' cash go? Meghmani Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 110 days in FY26, up from 106 days in FY21. It spent ₹378 Cr on assets over the last 3 years. Customers take 113 days to pay, and stock sits for 145 days on average. At FY26 sales of ₹2,174 Cr, each day of that cycle ties up about ₹6.0 Cr, so roughly ₹655 Cr is tied up in the business at any time. FY26: customers took 113 days to pay and stock sat for 145 days, about 4.8 months of sales sitting as stock, for a full cycle of 110 days, longer than FY21's 106. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 145 days. Customers pay about 113 days after that. Suppliers are paid at 149 days. Together that makes the 110-day cycle. Spending on assets: ₹378 Cr over the last 3 years, against ₹319 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹87.0 Cr (FY26): assets paid for that are not earning yet. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Meghmani Organics' P/E ratio, and how does it compare with its own history? Meghmani Organics Ltd's P/E is 21.8×, in the middle of its own history: higher than 58% of past readings. Its usual P/E (the middle reading) is 13.6×, over 5.2 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Where the price move came from: over 5 years the price moved −11.9% a year; about −21.7% a year came from earnings growth and about +9.8 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Meghmani Organics business getting better or worse? Meghmani Organics Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Meghmani Organics earn on its capital? Meghmani Organics Ltd earned a ROCE of 7% in FY26. That is up from a low of −3% in FY24. Its return on capital used (ROIC) is 9.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 1.3% net margin and 0.72× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 1.3% net margin × 0.72× asset turnover × 1.96× leverage (assets divided by equity) ≈ 1.8% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 2.4% − 12.0% = −9.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 2.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 1.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Meghmani Organics have too much debt? Meghmani Organics Ltd has total debt of ₹726 Cr against shareholder equity of ₹1,545 Cr as of Jun 2026, so its debt is 0.47× its equity. Year by year, that ratio went from 0.34 in FY22 to 0.47 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Meghmani Organics shareholding pattern? Foreign institutions cut their stake in Meghmani Organics Ltd by 1.4 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 0.8% of the company. Promoters moved −0.4 points over the same period, to 49.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −1.4 points over 8 quarters, to 0.8%; Promoters: −0.4 points over 8 quarters, to 49.0%; Domestic institutions: −0.4 points over 8 quarters, to 0.0%. Why the owners changed: foreign institutions drove it (−1.4 points). They reduced their stake. ## How far is Meghmani Organics from balance-sheet trouble? For Meghmani Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Meghmani Organics rank in its industry? 52.1 out of 100, rank 10 of 25 in Pesticides/Agrochemicals, with 64% of the evidence available. Meghmani Organics Ltd scores 52.1 out of 100 against the 25 companies it is compared with in Pesticides/Agrochemicals, ranking 10. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 22 + 9.5 + 9.6 + 11 = 52.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Meghmani Organics compared with? Meghmani Organics ranks 10 of 25 Pesticides/Agrochemicals companies on the 4-Factor Sector Score, with 52.1 out of 100. 1. [Sharda Cropchem Ltd](https://www.sectoralpha.in/stocks/sharda-cropchem-ltd) SHARDACROP · basing · Most evidence points up · 100% evidence 71.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 17.3% · Profit 42.5% · Operating margin change 2 points · 100% evidence Capital efficiency 19.5/25 · ROCE 30.2% · Operating margin 16% · 100% evidence Valuation 19.2/20 · P/E 9.3× · PEG 0.3 · 100% evidence Relative strength 4.6/20 · Lead over its industry -14.3% · Lead over NIFTY 500 -22.1% · 1 year -23.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.5 + 19.5 + 19.2 + 4.6 = 71.8 · What this means: Earnings are strong; relative strength in its sector is -14.3% and the one-year return is -23.1%. 2. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) turning · Most evidence points up · 83% evidence 70.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.1/35 · Revenue 31.8% · Profit 38.7% · Operating margin change 2 points · 83% evidence Capital efficiency 20.2/25 · ROCE 22.8% · Operating margin 21% · 95% evidence Valuation 5.4/20 · P/E 51.8× · PEG n/a · 50% evidence Relative strength 16.7/20 · Lead over its industry 38.3% · Lead over NIFTY 500 25.1% · 1 year 101.5% · 100% evidence · 4 of 12 weeks ahead Exact sum: 28.1 + 20.2 + 5.4 + 16.7 = 70.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Bayer CropScience Ltd](https://www.sectoralpha.in/stocks/bayer-cropscience-ltd) BAYERCROP · quiet · Evidence leans up · 81% evidence 63.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue -2.8% · Profit 23.8% · Operating margin change 2 points · 88% evidence Capital efficiency 19.6/25 · ROCE 29.1% · Operating margin 20% · 100% evidence Valuation 13.4/20 · P/E 20× · PEG 1.28 · 100% evidence Relative strength 8.6/20 · Lead over its industry n/a · Lead over NIFTY 500 -20.8% · 1 year -33.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 19.6 + 13.4 + 8.6 = 63.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) PUNJABCHEM · quiet · Evidence leans up · 81% evidence 63.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.3/35 · Revenue 8.2% · Profit 43.5% · Operating margin change 1 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.6% · Operating margin 12% · 100% evidence Valuation 15.9/20 · P/E 17.4× · PEG 0.33 · 100% evidence Relative strength 9.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -9.4% · 1 year -36.4% · 25% evidence · 6 of 12 weeks ahead Exact sum: 24.3 + 13.6 + 15.9 + 9.8 = 63.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Dharmaj Crop Guard Ltd](https://www.sectoralpha.in/stocks/dharmaj-crop-guard-ltd) DHARMAJ · losing its lead · Evidence leans up · 81% evidence 63.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 8.7% · Profit 13.2% · Operating margin change 1 points · 88% evidence Capital efficiency 14.7/25 · ROCE 16.8% · Operating margin 15% · 100% evidence Valuation 17.5/20 · P/E 14.3× · PEG 0.38 · 100% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 4.7% · 1 year -9.9% · 25% evidence · 3 of 12 weeks ahead Exact sum: 18.8 + 14.7 + 17.5 + 12.2 = 63.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) IPL · quiet · Evidence leans up · 81% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Revenue 17% · Profit 10.1% · Operating margin change -2 points · 88% evidence Capital efficiency 15.4/25 · ROCE 16.6% · Operating margin 14% · 100% evidence Valuation 18.2/20 · P/E 12× · PEG 0.36 · 100% evidence Relative strength 8.2/20 · Lead over its industry n/a · Lead over NIFTY 500 -23% · 1 year -40.7% · 25% evidence · 0 of 12 weeks ahead Exact sum: 17.6 + 15.4 + 18.2 + 8.2 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Advance Agrolife Ltd](https://www.sectoralpha.in/stocks/advance-agrolife-ltd) ADVANCE · breaking out · Evidence leans up · 64% evidence 58.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue 48.4% · Profit 81.5% · Operating margin change 1 points · 88% evidence Capital efficiency 14.1/25 · ROCE 19.6% · Operating margin 11% · 100% evidence Valuation 10.3/20 · P/E 16.3× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 10.6% · 1 year -8.6% · 25% evidence · 12 of 12 weeks ahead Exact sum: 22.1 + 14.1 + 10.3 + 12.4 = 58.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Dhanuka Agritech Ltd](https://www.sectoralpha.in/stocks/dhanuka-agritech-ltd) DHANUKA · turning · Evidence leans up · 100% evidence 57.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.8/35 · Revenue 0% · Profit 0.7% · Operating margin change 0 points · 100% evidence Capital efficiency 19.6/25 · ROCE 25.9% · Operating margin 23% · 100% evidence Valuation 9.2/20 · P/E 14.4× · PEG 2.27 · 100% evidence Relative strength 17.4/20 · Lead over its industry 7.1% · Lead over NIFTY 500 -2.8% · 1 year -28.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10.8 + 19.6 + 9.2 + 17.4 = 57 · What this means: Relative strength against the index is -2.8%, and revenue and profit growth are weak. 9. [Jubilant Ingrevia Ltd](https://www.sectoralpha.in/stocks/jubilant-ingrevia-ltd) JUBLINGREA · quiet · Evidence leans up · 93% evidence 54.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 26.0/35 · Revenue 15.4% · Profit 21.9% · Operating margin change 3 points · 100% evidence Capital efficiency 13.6/25 · ROCE 11.4% · Operating margin 15% · 100% evidence Valuation 6.7/20 · P/E 24.7× · PEG 2.26 · 65% evidence Relative strength 8.4/20 · Lead over its industry -2.6% · Lead over NIFTY 500 -11.7% · 1 year -19.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 26 + 13.6 + 6.7 + 8.4 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Meghmani Organics Ltd this page MOL · breaking out · Evidence leans up · 64% evidence 52.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.0/35 · Revenue -7.8% · Profit 100% · Operating margin change 7 points · 88% evidence Capital efficiency 9.5/25 · ROCE 6.7% · Operating margin 18% · 100% evidence Valuation 9.6/20 · P/E 20.8× · PEG n/a · 15% evidence Relative strength 11.0/20 · Lead over its industry n/a · Lead over NIFTY 500 -0.5% · 1 year -35% · 25% evidence · 11 of 12 weeks ahead Exact sum: 22 + 9.5 + 9.6 + 11 = 52.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [GSP Crop Science Ltd](https://www.sectoralpha.in/stocks/gsp-crop-science-ltd) GSPCROP · quiet · Too little evidence to rank firmly · 59% evidence 51.0 out of 100 Growth Capital Valuation Relative
12. [Epigral Ltd](https://www.sectoralpha.in/stocks/epigral-ltd) EPIGRAL · quiet · Evidence leans down · 81% evidence 49.6 out of 100 Growth Capital Valuation Relative
13. [Rallis India Ltd](https://www.sectoralpha.in/stocks/rallis-india-ltd) RALLIS · quiet · Evidence leans down · 85% evidence 48.4 out of 100 Growth Capital Valuation Relative
14. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) BHARATRAS · quiet · Evidence leans down · 96% evidence 45.3 out of 100 Growth Capital Valuation Relative
15. [Bhagiradha Chemicals & Industries Ltd](https://www.sectoralpha.in/stocks/bhagiradha-chemicals-industries-ltd) BHAGCHEM · quiet · Evidence leans down · 96% evidence 44.7 out of 100 Growth Capital Valuation Relative
16. [Shivalik Rasayan Ltd](https://www.sectoralpha.in/stocks/shivalik-rasayan-ltd) SHIVALIK · Evidence leans down · 63% evidence 43.9 out of 100 Growth Capital Valuation Relative
17. [Excel Industries Ltd](https://www.sectoralpha.in/stocks/excel-industries-ltd) EXCELINDUS · quiet · Evidence leans down · 64% evidence 42.7 out of 100 Growth Capital Valuation Relative
18. [NACL Industries Ltd](https://www.sectoralpha.in/stocks/nacl-industries-ltd) NACLIND · basing · Evidence leans down · 96% evidence 42.0 out of 100 Growth Capital Valuation Relative
19. [Best Agrolife Ltd](https://www.sectoralpha.in/stocks/best-agrolife-ltd) BESTAGRO · quiet · Evidence leans down · 90% evidence 42.0 out of 100 Growth Capital Valuation Relative
20. [Sumitomo Chemical India Ltd](https://www.sectoralpha.in/stocks/sumitomo-chemical-india-ltd) SUMICHEM · quiet · Evidence leans down · 85% evidence 41.7 out of 100 Growth Capital Valuation Relative
21. [UPL Ltd](https://www.sectoralpha.in/stocks/upl-ltd) UPL · basing · Evidence leans down · 71% evidence 41.5 out of 100 Growth Capital Valuation Relative
22. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) INSECTICID · quiet · Evidence leans down · 96% evidence 40.5 out of 100 Growth Capital Valuation Relative
23. [P I Industries Ltd](https://www.sectoralpha.in/stocks/p-i-industries-ltd) PIIND · quiet · Evidence leans down · 81% evidence 38.3 out of 100 Growth Capital Valuation Relative
24. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ASTEC · quiet · Most evidence points down · 71% evidence 32.7 out of 100 Growth Capital Valuation Relative
25. [Heranba Industries Ltd](https://www.sectoralpha.in/stocks/heranba-industries-ltd) HERANBA · quiet · Most evidence points down · 76% evidence 29.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Pesticides/Agrochemicals](https://www.sectoralpha.in/sectors/pesticides-agrochemicals), all 25 compared on one page. ## Which companies are close to Meghmani Organics in size? Meghmani Organics is the 16th largest of 25 Pesticides/Agrochemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Titan Biotech, Bharat Rasayan and Insecticides India. Just below it: India Pesticides, Astec Lifesciences and Punjab Chemicals & Crop Protection. ### Pesticides/Agrochemicals companies close in size

1. [Titan Biotech Ltd](https://www.sectoralpha.in/stocks/titan-biotech-ltd) ₹1,755 crore
2. [Bharat Rasayan Ltd](https://www.sectoralpha.in/stocks/bharat-rasayan-ltd) ₹1,557 crore
3. [Insecticides India Ltd](https://www.sectoralpha.in/stocks/insecticides-india-ltd) ₹1,511 crore
4. Meghmani Organics Ltd ₹1,339 crore
5. [India Pesticides Ltd](https://www.sectoralpha.in/stocks/india-pesticides-ltd) ₹1,297 crore
6. [Astec Lifesciences Ltd](https://www.sectoralpha.in/stocks/astec-lifesciences-ltd) ₹1,216 crore
7. [Punjab Chemicals & Crop Protection Ltd](https://www.sectoralpha.in/stocks/punjab-chemicals-crop-protection-ltd) ₹1,166 crore

[All 25 Pesticides/Agrochemicals companies, largest first](https://www.sectoralpha.in/sectors/pesticides-agrochemicals#all-companies)

### Companies close in size in other industries

1. [Skyways Air Services Ltd](https://www.sectoralpha.in/stocks/skyways-air-services-ltd) ₹1,344 crore
2. [Rico Auto Industries Ltd](https://www.sectoralpha.in/stocks/rico-auto-industries-ltd) ₹1,342 crore · Auto Ancillaries - Spare Parts Accessories
3. Meghmani Organics Ltd ₹1,339 crore
4. [AVT Natural Products Ltd](https://www.sectoralpha.in/stocks/avt-natural-products-ltd) ₹1,338 crore · Agricultural Processing - Maize
5. [Gala Precision Engineering Ltd](https://www.sectoralpha.in/stocks/gala-precision-engineering-ltd) ₹1,331 crore · Castings, Forgings & Fastners

## What else do people ask about Meghmani Organics? ### What is Meghmani Organics's share price today? Meghmani Organics Ltd's share price is ₹55.25, −31.8% over the past year. The whole company is worth ₹1,404 Cr on the market. In the last 52 weeks it traded between ₹39 to ₹75; today it is 45% of the way up from the low, 5.0% below its 200-day average (as of 3 November 2026). ### What were Meghmani Organics's latest quarterly results? Meghmani Organics Ltd reported revenue of ₹543 Cr and net profit of ₹48.0 Cr for the Jun 2026 quarter. Revenue fell 11.6% and profit rose 269.2% compared with a year earlier. Earnings per share were ₹1.89. The operating margin was 18.0%, 7.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Meghmani Organics's market cap? Meghmani Organics Ltd's market capitalisation is ₹1,404 Cr at a share price of ₹55.25. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Meghmani Organics performing? Meghmani Organics Ltd's share price has been rising for 3 weeks. In its latest quarter, revenue fell 11.6% and profit rose 269.2% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 1 week running (as of 3 November 2026). ### Will Meghmani Organics's share price go up? This page does not forecast Meghmani Organics Ltd's share price. What it shows instead: the share price is ₹55.25, and it has been rising for 3 weeks. Its P/E of 21.8× is higher than 58% of its own last 5 years (as of 3 November 2026). ### Who owns Meghmani Organics? Promoters own 49.0% of Meghmani Organics Ltd, foreign institutions 0.8%, domestic institutions 0.0% and the public 50.2% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 1.4 percentage points over 8 quarters (as of 3 November 2026). ### Does Meghmani Organics have too much debt? Meghmani Organics Ltd has a moderate amount of debt: its debt is 0.47× its equity, and its operating profit is 2 times its interest bill. FY26 borrowings were ₹726 Cr against equity of ₹1,544 Cr. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Meghmani Organics in its business cycle? Meghmani Organics Ltd's FY26 operating margin was 8.0%, against a 7-year range of −1.2% to 17.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 18.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Meghmani Organics story? Biggest thing to watch: the price has already been rising for 3 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Meghmani Organics a stock worth studying right now? What the numbers show: Meghmani Organics Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Meghmani Organics share price forecast for 2026? What management itself guided: Consolidated and Crop Protection topline growth in double digits over the next 3-5 years; technical/formulation mix planned toward 50:50 from 60:40. ## Lists

- Undervalued stocks: https://www.sectoralpha.in/markets/in/deep-value-stocks
- Breakout stocks: https://www.sectoralpha.in/breakout-stocks-india
- Penny stocks: https://www.sectoralpha.in/penny-stocks-india

This is research, not advice. We’re not SEBI-registered.